Krystal Biotech Inc (KRYS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 392,604 | 353,829 | 308,770 | 344,865 | 373,966 |
| Marketable Securities | 338,465 | 328,157 | 308,076 | 252,652 | 214,358 |
| Receivables | 129,633 | 111,439 | 103,260 | 104,746 | 97,298 |
| Inventories | 37,632 | 31,041 | 29,942 | 26,508 | 18,581 |
| Income taxes - deferred | 10,103 | N/A | N/A | 1,617 | N/A |
| TOTAL | $925,650 | $841,347 | $766,798 | $742,045 | $713,164 |
| Non-Current Assets | |||||
| PPE Net | 148,871 | 150,388 | 151,070 | 155,168 | 156,592 |
| Investments And Advances | 133,113 | 138,807 | 148,472 | 152,114 | 105,888 |
| Other Non-Current Assets | 32,460 | 7,852 | 8,076 | 6,511 | 6,674 |
| TOTAL | $314,444 | $297,047 | $307,618 | $313,793 | $269,154 |
| Total Assets | $1,240,094 | $1,138,394 | $1,074,416 | $1,055,838 | $982,318 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,097 | 7,124 | 2,672 | 4,985 | 5,580 |
| Accrued Expenses | 87,473 | 78,155 | 75,455 | 95,793 | 82,655 |
| TOTAL | $91,268 | $86,896 | $79,489 | $101,995 | $89,527 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 10,950 | 10,851 | 10,253 | 7,463 | 6,945 |
| TOTAL | $10,950 | $10,851 | $10,253 | $7,463 | $6,945 |
| Total Liabilities | $102,218 | $97,747 | $89,742 | $109,458 | $96,472 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 28,998 | 28,943 | 28,899 | 28,806 | 28,761 |
| Retained earnings | -27,237 | -106,602 | -144,935 | -180,668 | -226,147 |
| Other shareholders' equity | 1,100 | 1,157 | 390 | -190 | 1,512 |
| TOTAL | $1,137,876 | $1,040,647 | $984,674 | $946,380 | $885,846 |
| Total Liabilities And Equity | $1,240,094 | $1,138,394 | $1,074,416 | $1,055,838 | $982,318 |